[go: up one dir, main page]

PT3030519T - Compostos de benzoxaborol tricíclicos e utilizações dos mesmos - Google Patents

Compostos de benzoxaborol tricíclicos e utilizações dos mesmos

Info

Publication number
PT3030519T
PT3030519T PT148342926T PT14834292T PT3030519T PT 3030519 T PT3030519 T PT 3030519T PT 148342926 T PT148342926 T PT 148342926T PT 14834292 T PT14834292 T PT 14834292T PT 3030519 T PT3030519 T PT 3030519T
Authority
PT
Portugal
Prior art keywords
benzoxaborole compounds
tricyclic benzoxaborole
tricyclic
compounds
benzoxaborole
Prior art date
Application number
PT148342926T
Other languages
English (en)
Original Assignee
Anacor Pharmaceuticals Inc
Glaxosmithkline Ip No 2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc, Glaxosmithkline Ip No 2 Ltd filed Critical Anacor Pharmaceuticals Inc
Publication of PT3030519T publication Critical patent/PT3030519T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/04Esters of boric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT148342926T 2013-08-09 2014-08-08 Compostos de benzoxaborol tricíclicos e utilizações dos mesmos PT3030519T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361864496P 2013-08-09 2013-08-09
US201361918976P 2013-12-20 2013-12-20

Publications (1)

Publication Number Publication Date
PT3030519T true PT3030519T (pt) 2022-01-27

Family

ID=52462052

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148342926T PT3030519T (pt) 2013-08-09 2014-08-08 Compostos de benzoxaborol tricíclicos e utilizações dos mesmos

Country Status (35)

Country Link
US (5) US20160251380A1 (pt)
EP (2) EP3030519B1 (pt)
JP (2) JP6499175B2 (pt)
KR (1) KR102093783B1 (pt)
CN (2) CN105492388B (pt)
AP (1) AP2016009046A0 (pt)
AU (2) AU2014305792C1 (pt)
BR (1) BR112016002651B1 (pt)
CA (1) CA2919888C (pt)
CL (1) CL2016000313A1 (pt)
CR (1) CR20160064A (pt)
CY (1) CY1125030T1 (pt)
DK (1) DK3030519T3 (pt)
DO (1) DOP2016000045A (pt)
EA (1) EA032844B1 (pt)
ES (1) ES2905413T3 (pt)
HR (1) HRP20220384T1 (pt)
HU (1) HUE057365T2 (pt)
IL (1) IL243874B (pt)
LT (1) LT3030519T (pt)
MX (1) MX375556B (pt)
MY (1) MY175823A (pt)
NZ (1) NZ716350A (pt)
PE (1) PE20160752A1 (pt)
PH (1) PH12016500234B1 (pt)
PL (1) PL3030519T3 (pt)
PT (1) PT3030519T (pt)
RS (1) RS62887B1 (pt)
SA (1) SA516370551B1 (pt)
SG (2) SG11201600787PA (pt)
SI (1) SI3030519T1 (pt)
SM (1) SMT202200113T1 (pt)
UA (1) UA116908C2 (pt)
WO (1) WO2015021396A2 (pt)
ZA (1) ZA201600792B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR094961A1 (es) * 2013-03-15 2015-09-09 Lilly Co Eli 1-hidroxi-benzooxaboroles como agentes antiparasitarios
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
SMT202200113T1 (it) 2013-08-09 2022-05-12 Glaxosmithkline Ip No 2 Ltd Composti di benzossaborolo triciclici e loro usi
CN106459097A (zh) 2014-07-01 2017-02-22 第三共株式会社 作为抗菌剂的三环苯并氧杂硼杂环戊烯类
MA41495A (fr) 2015-02-12 2017-12-19 Anacor Pharmaceuticals Inc Composés benzoxaborole et leurs utilisations
EP3578562B1 (en) 2016-05-12 2021-06-23 Anacor Pharmaceuticals, Inc L-valinate amide benzoxaborole derivatives for the treatment of parasitic diseases
CN109387594B (zh) * 2017-08-08 2021-01-19 武汉武药科技有限公司 一种分离和分析贝达喹啉光学异构体的方法
WO2019138422A1 (en) * 2018-01-09 2019-07-18 Halcyon Labs Private Limited Process for the preparation of crisaborole and its intermediates
EP4164645A4 (en) * 2020-06-15 2024-07-10 The Global Alliance for TB Drug Development, Inc. COMBINED ANTIBACTERIAL COMPOSITION AND ANTIBACTERIAL THERAPY METHOD
CN111606850B (zh) * 2020-07-07 2023-07-25 安徽贝克生物制药有限公司 贝达喹啉及其中间体的制备方法
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
JP2025520237A (ja) * 2022-06-23 2025-07-03 ミクウルク ファーマシューティカルズ, インコーポレイテッド ホウ素化合物を用いて非結核性マイコバクテリア感染症を治療する方法及びその用途、並びに同じ疾患を治療するための医薬組成物
WO2023246842A1 (en) * 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Prodrugs of boron compounds and their use in treating bacterial infections
WO2024208907A1 (en) 2023-04-05 2024-10-10 Glaxosmithkline Intellectual Property (No. 2) Limited Synthesis of 3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3h)-ol

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632955B1 (en) 1996-12-02 2003-10-14 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
DE60313357T2 (de) 2002-12-02 2008-01-03 Solvias Ag Verfahren zur katalytischen hydrierung von kohlenstoff-heteroatom-doppelbindungen
RU2414906C2 (ru) * 2005-02-16 2011-03-27 Анакор Фармасьютикалз, Инк. Борсодержащие малые молекулы
JP5084717B2 (ja) 2005-03-08 2012-11-28 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ キラル・ビスオキサゾリン触媒
CN101505603A (zh) * 2005-12-30 2009-08-12 安纳考尔医药公司 含硼的小分子
CN106008571A (zh) 2005-12-30 2016-10-12 安纳考尔医药公司 含硼的小分子
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
JP2012512262A (ja) 2008-12-17 2012-05-31 アナコール ファーマシューティカルズ,インコーポレーテッド (s)−3−アミノメチル−7−(3−ヒドロキシ−プロポキシ)−3h−ベンゾ[c][1,2]オキサボロール−1−オールの多形体
WO2011127143A1 (en) * 2010-04-07 2011-10-13 Glaxosmithkline Llc Process for preparing benzoxaboroles
CN108610356B (zh) * 2010-09-07 2021-02-26 阿纳科制药公司 苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染
EP2793901A1 (en) * 2011-12-22 2014-10-29 Micurx Pharmaceuticals, Inc. Tricyclic boron compounds for antimicrobial therapy
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
SMT202200113T1 (it) 2013-08-09 2022-05-12 Glaxosmithkline Ip No 2 Ltd Composti di benzossaborolo triciclici e loro usi
MA41495A (fr) * 2015-02-12 2017-12-19 Anacor Pharmaceuticals Inc Composés benzoxaborole et leurs utilisations

Also Published As

Publication number Publication date
JP6499175B2 (ja) 2019-04-10
CN110003253A (zh) 2019-07-12
KR20160038901A (ko) 2016-04-07
US20200095266A1 (en) 2020-03-26
KR102093783B1 (ko) 2020-03-26
US20190241586A1 (en) 2019-08-08
CL2016000313A1 (es) 2016-09-23
SG10201914073PA (en) 2020-03-30
ES2905413T3 (es) 2022-04-08
MX2016001732A (es) 2016-05-18
AU2014305792A1 (en) 2016-03-10
US20180044355A1 (en) 2018-02-15
UA116908C2 (uk) 2018-05-25
CN105492388B (zh) 2018-12-21
EP3030519A2 (en) 2016-06-15
EP3030519B1 (en) 2022-01-05
SI3030519T1 (sl) 2022-04-29
CR20160064A (es) 2016-06-01
BR112016002651A2 (pt) 2017-08-01
DK3030519T3 (da) 2022-01-31
CA2919888A1 (en) 2015-02-12
AP2016009046A0 (en) 2016-02-29
JP2016527321A (ja) 2016-09-08
PH12016500234B1 (en) 2019-01-30
CN105492388A (zh) 2016-04-13
WO2015021396A9 (en) 2016-02-11
MY175823A (en) 2020-07-10
EP3030519A4 (en) 2017-03-08
JP6764970B2 (ja) 2020-10-07
HUE057365T2 (hu) 2022-05-28
IL243874B (en) 2018-11-29
US20160251380A1 (en) 2016-09-01
JP2019123727A (ja) 2019-07-25
NZ716350A (en) 2022-12-23
CN110003253B (zh) 2022-03-18
HRP20220384T1 (hr) 2022-07-22
ZA201600792B (en) 2022-05-25
HK1219939A1 (zh) 2017-04-21
SG11201600787PA (en) 2016-03-30
AU2014305792B2 (en) 2017-05-04
PE20160752A1 (es) 2016-08-17
AU2017210567A1 (en) 2017-08-24
PL3030519T3 (pl) 2022-05-23
RS62887B1 (sr) 2022-03-31
AU2014305792C1 (en) 2018-07-05
PH12016500234A1 (en) 2016-05-16
EA201690135A1 (ru) 2016-07-29
LT3030519T (lt) 2022-04-11
CY1125030T1 (el) 2023-03-24
WO2015021396A2 (en) 2015-02-12
SA516370551B1 (ar) 2017-10-31
US10526352B2 (en) 2020-01-07
US10308668B2 (en) 2019-06-04
SMT202200113T1 (it) 2022-05-12
WO2015021396A3 (en) 2015-10-29
US20210053999A1 (en) 2021-02-25
CA2919888C (en) 2022-10-18
MX375556B (es) 2025-03-06
US10858376B2 (en) 2020-12-08
AU2017210567B2 (en) 2019-08-01
EA032844B1 (ru) 2019-07-31
IL243874A0 (en) 2016-04-21
EP4029870A1 (en) 2022-07-20
BR112016002651B1 (pt) 2022-11-29
DOP2016000045A (es) 2016-04-29

Similar Documents

Publication Publication Date Title
IL274355B (en) Aza-pyridone compounds and their uses
PT3381917T (pt) Compostos imidazopiridina e suas utilizações
ZA201600792B (en) Tricyclic benzoxaborole compounds and uses thereof
PT3003039T (pt) Compostos piridinona-piridinilo substituídos com metil/fluoro-piridinil-metoxilo e compostos piridinona-pirimidinilo substituídos com fluoro-pirimidinil-metoxilo
GB201323008D0 (en) Compounds and uses thereof
IL240788B (en) Heterocyclic compounds and their uses
GB201317969D0 (en) Padlock
GB201321693D0 (en) Composition and uses thereof
GB201312318D0 (en) Novel methods and compounds
GB201300707D0 (en) Compounds and processes
GB201307233D0 (en) Compounds and uses thereof
GB201320992D0 (en) Complex and uses thereof
ZA201601880B (en) Hetero-transglycosylase and uses thereof
GB201309180D0 (en) Compounds and Their Uses
GB201314610D0 (en) Compounds and their uses
GB201306248D0 (en) Compounds and their uses
GB201320161D0 (en) Compounds and their uses
GB201323005D0 (en) Compounds and uses thereof
GB201307202D0 (en) New compounds and uses
GB201307201D0 (en) New compounds and uses
GB201301734D0 (en) New compounds and uses
GB201309248D0 (en) Compounds and combinations
GB201313605D0 (en) Novel compounds and their use
GB201301022D0 (en) Composition and uses thereof
GB201301393D0 (en) Kiddibidet and pottibidet